Screener
Rhythm Pharmaceuticals, Inc. RYTM Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLongTermInvestments.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Right-of-use asset | 2,936 | 3,049 |
| Intangible assets, net | 5,106 | 5,319 |
| Restricted cash | 601 | 522 |
| Other long-term assets | 2,518 | 3,286 |
| Total assets | $442,316 | $480,196 |
| Liabilities, Convertible Preferred Stock and Stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $12,299 | $13,947 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s other non-current assets?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported other non-current assets of $2.52M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s other non-current assets changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s other non-current assets decreased by 64.8% year-over-year, from $7.14M to $2.52M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s other non-current assets?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s other non-current assets has grown at a -27.4% compound annual growth rate (CAGR), from $11.82M to $3.29M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude